Fit-for-Purpose Biomarker Assay Validation Strategies

Time: 3:30 pm
day: Track A - Day 2 pm


• UCB’s approach to fit-for-purpose biomarker assay validation
• How biomarker context of use impacts assay decisions in order to fulfil the need in a clinical trial
• Examples across the use of ligand binding assay, flow cytometry and qPCR assays